Minds and Mentors Program- R33

Inclusion Criteria:

1. Age 19 and older

2. Opioid Use disorder diagnosis based on DSM-V criteria in the past 30 days

3. Currently receiving MOUD (e.g. methadone, naloxone, naltrexone, and buprenorphine)from an established provider

4. Are within maintenance phase of MOUD (not actively detoxing)

5. May meet criteria for a mood, anxiety, or other psychiatric disorder based on theDSM-V criteria. Participants on maintenance medications for a mood or anxietydisorder must be stabilized on medications for at least 2 weeks before therapyinitiation

6. Capable of reading and understanding English

7. Able to provide written informed consent (i.e. no surrogate)

8. Access to a smartphone or a computer with an internet connection

9. Willing to commit to 12 group therapy sessions, baseline, and follow-up assessmentsfor 24 weeks after the end of treatment (9- month total)

Exclusion Criteria:

1. Significant cognitive impairment

2. Women who are pregnant (does not impact eligibility post study initiation)

3. Actively suicidal or homicidal

4. Active psychosis and/ or

5. Unstable medical conditions that contraindicate proposed treatment

Subject Exit criteria:

1. Increases in alcohol or drug use leading to the need for a more intensive level ofcare (i.e., medical detoxification, inpatient)

2. Newly developed active suicidal or homicidal ideation

3. Inability to manage psychiatric symptoms within the inclusion/exclusion criteria ofthe study (i.e., need for the initiation of maintenance psychotropic medications;development of psychosis). If it is determined, based on clinical criteria, that aparticipant needs to be started on maintenance medications for anxiety, mood orpsychotic symptoms during the study, they will be discontinued from the treatmenttrial

4. Inability to return for therapy sessions for four consecutive weeks.